Great Basin Scientific Inc. (fka GBSNQ)

[stockmaster007]

Confirmed with IR that they are expecting word back on another FDA approval test-Stool Bacterial Pathogens Panel.

Also that moving forward the company is working toward financing instruments that have less dilutive consequences for our shareholder base. I don't think we will see a RS. They have more revenues and the growth is clear. Not to mention another FDA approval and another on the way. Lenders are more likely to lend now than before. Also, not ruling out a hostile buyout when you look at QDEL, NexGen, Qiagen, and others. All of which are trading over 12.00.